Transcatheter Arterial Chemoembolization (TACE) to Treat Primary or Metastatic Liver Malignancies

Transcatheter Arterial Chemoembolization to Treat Primary or Metastatic Liver Malignancies

Transcatheter Arterial Chemoembolization (TACE) to Treat Primary or Metastatic Liver Malignancies

©2017 Blue Cross and Blue Shield of Louisiana An independent licensee of the Blue Cross and Blue Shield Association No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from Blue Cross and Blue Shield of Louisiana. Page 1 of 22 Applies to all products admin...

8.01.505 Transcatheter Arterial Chemoembolization as a Treatment for Primary or Metastatic Liver Malignancies

Ischemic complications of transcatheter arterial chemoembolization in liver malignancies.

OBJECTIVE To determine the frequency, character, methods of treatment, and outcome of ischemic complications after transcatheter hepatic artery chemoembolization (TACE). MATERIAL AND METHODS Between 1985 and 1998, 827 sessions of TACE with Doxorubicin mixed with iodized oil, and gelatin sponge particles were performed in 282 patients with primary and metastatic liver cancer. Post-TACE monitor...

Interventional oncology on a C-arm system with XperCT: targeting liver cancer

Imaging plays a key role in interventional oncologic procedures such as transcatheter arterial chemoembolization (TACE) and percutaneous portal vein embolization (PVE). TACE delivers highly concentrated doses of chemotherapy to the tumor bed, while sparing the surrounding hepatic parenchyma [1, 2]. TACE has gained wide acceptance over the past twenty years and is now considered the main therapy...